These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25131004)

  • 1. Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.
    Parikh M; Hynan LS; Weiner MF; Lacritz L; Ringe W; Cullum CM
    Clin Neuropsychol; 2014; 28(6):926-40. PubMed ID: 25131004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CVLT-II short form forced choice recognition in a clinical dementia sample: Cautions for performance validity assessment.
    Grewal KS; Trites M; Kirk A; MacDonald SWS; Morgan D; Gowda-Sookochoff R; O'Connell ME
    Appl Neuropsychol Adult; 2024; 31(5):839-848. PubMed ID: 35635794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.
    Steenland K; Zhao L; Goldstein FC; Levey AI
    J Am Geriatr Soc; 2013 Sep; 61(9):1449-55. PubMed ID: 24000778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.
    Loring DW; Goldstein FC; Chen C; Drane DL; Lah JJ; Zhao L; Larrabee GJ;
    Arch Clin Neuropsychol; 2016 Jun; 31(4):313-31. PubMed ID: 27084732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.
    Hayden KM; Kuchibhatla M; Romero HR; Plassman BL; Burke JR; Browndyke JN; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1364-74. PubMed ID: 24080384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.
    Kim J; Na HK; Byun J; Shin J; Kim S; Lee BH; Na DL
    Dement Geriatr Cogn Disord; 2017; 44(1-2):105-117. PubMed ID: 28768247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steeper memory decline after COVID-19 lockdown measures.
    Bakker ED; van der Pas SL; Zwan MD; Gillissen F; Bouwman FH; Scheltens P; van der Flier WM; van Maurik IS
    Alzheimers Res Ther; 2023 Apr; 15(1):81. PubMed ID: 37061745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Mild Cognitive Impairment in Essential Tremor: How Many and Which Neuropsychological Tests?
    Cersonsky TEK; Morgan S; Kellner S; Robakis D; Liu X; Huey ED; Louis ED; Cosentino S
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1084-1098. PubMed ID: 30303051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.
    Amariglio RE; Donohue MC; Marshall GA; Rentz DM; Salmon DP; Ferris SH; Karantzoulis S; Aisen PS; Sperling RA;
    JAMA Neurol; 2015 Apr; 72(4):446-54. PubMed ID: 25706191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.